What BioScript Solutions does

BioScript Solutions is a privately held Canadian specialty healthcare company founded in 2001 and headquartered in Moncton, New Brunswick. The company operates an integrated platform spanning specialty pharmacy (13 BioScript Pharmacies), infusion and injection clinics (100+ Coverdale Clinics locations), wholesale pharmaceutical distribution (A&D Wholesale), manufacturer-funded patient support programs (NavieGo), and third-party logistics (BioScript Logistics) serving patients in every Canadian province from Victoria, BC to St. John's, NL. Its primary customers are patients with chronic illnesses and rare diseases requiring complex specialty drug therapies, with secondary B2B customers including pharmaceutical manufacturers seeking Canadian market access, physicians and healthcare practitioners, and payors.

The underlying platform combines proprietary NavieGo patient management software, integrated wholesale and 3PL logistics infrastructure in Mississauga, Ontario, and a clinical footprint that processes over 1 million prescriptions annually with 90%+ patient satisfaction across its pharmacy network. The company monetizes across multiple revenue streams — transaction-fee pharmacy dispensing, subscription/recurring manufacturer-funded patient support programs, wholesale distribution margins, managed-services 3PL contracts, and professional-services clinic and nursing fees — distributed across four customer segments (patients, manufacturers, physicians, payors). Co-founders David Ford and Andrew Steeves remain in ownership and strategic roles following the May 2023 transition to Lisa Matar as the first non-founder CEO, who joined from Eli Lilly Canada.

The company employs 1,000+ people across Canada and has earned Canada's Best Managed Companies recognition for five consecutive years (2021–2025, Gold Standard in 2024 and 2025). Recent strategic moves include Quebec expansion via Pharmacie Benoît Picard (October 2024), a 30-position New Brunswick expansion with provincial government support (2024), and senior leadership hires in 2023–2026 (CIO from banking/digital transformation, VP Wholesale & Logistics from Amazon Canada and McKesson) suggesting continued platform professionalization and potential future transaction readiness.

Name

BioScript Solutions

Legal name

BioScript Solutions

Website

https://bioscript.ca

Company type

Private

Founded year

2001

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BioScript Solutions is a privately held Canadian specialty healthcare company operating 100+ infusion clinics, 13 specialty pharmacies, wholesale distribution, manufacturer-funded patient support programs, and 3PL services for patients with chronic illnesses and pharmaceutical manufacturers across every Canadian province.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacies and Drug Retailers (45611), Pharmacies and Drug Retailers (456110)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharmacy & Biologics Distribution (CRAOAHAD)

akta.pro secondary industries

Specialty Injectable & Infusion Therapies (Cross-therapeutic) (HLAIACAO), Specialty Pharma & Biologics Distribution (GDP-compliant) (HLAGAMAD), Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG), Patient Access Programs & Affordability (Copay/Hubs/PSP) (HLAIAKAG)

Keywords

• Specialty pharmacy services
• Patient support programs
• Infusion clinic services
• Pharmaceutical wholesale distribution
• Specialty drug therapies

Headquarters

HQ city

Moncton

HQ country

Canada

HQ region

North America

Offices8 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

1. Pharmacy Services: Specialty pharmacy services dispensing complex drug therapies with home delivery and in-clinic administration. Revenue generated from prescription processing and medication dispensing for patients with chronic illnesses and rare diseases.
2. Patient Support Programs: NavieGo programs providing enrollment, clinical support, treatment coordination and adherence monitoring for patients on specialty medications. Services contracted by pharmaceutical manufacturers.
3. Wholesale Distribution: A&D Wholesale distribution of specialty pharmaceuticals to hospitals, healthcare providers and pharmacies nationwide.
4. Third-Party Logistics (3PL): BioScript Logistics providing Canadian gateway services for global pharma and biotech companies including importation, storage and distribution.
5. Clinic and Nursing Services: Coverdale Clinics providing infusion and injection services with nursing staff, including iron infusions and other specialty treatments.

Go-to-market motion1 record

Distribution channels5 records

Marketing channels7 records

Core offering

BioScript Solutions delivers full-service specialty care across an integrated platform of specialty pharmacy dispensing (BioScript Pharmacy), in-clinic infusion and injection treatments (Coverdale Clinics), patient enrollment and adherence support programs (NavieGo), wholesale pharmaceutical distribution (A&D Wholesale), and third-party logistics for medication importation and storage (BioScript Logistics). The company focuses on patients with chronic illnesses and rare diseases who require complex specialty drug therapies, supporting them from enrollment through treatment administration and adherence monitoring.

Product overview

BioScript Solutions is a full-service specialty healthcare company operating a platform of interconnected services spanning pharmacy, clinics, wholesale distribution, patient support programs, and third-party logistics. The core offerings include BioScript Pharmacy (specialty medication dispensing and delivery), Coverdale Clinics (infusion and injection treatments at 100+ locations), A&D Wholesale (pharmaceutical distribution to healthcare providers nationwide), NavieGo Programs (patient enrollment, clinical support, and medication adherence), and BioScript Logistics (3PL services for pharma importation and distribution). The company serves patients with chronic illnesses and rare diseases, as well as pharmaceutical manufacturers, payors, and healthcare practitioners across Canada.

Differentiator

Problem solved

Functional benefit

Products and services

• BioScript Pharmacy Specialty pharmacy providing specialty medications, medication counselling, and home delivery directly to patients with chronic illnesses and rare diseases across Canada.
• Coverdale Clinics Network of 100+ specialty infusion and injection clinics providing patients with a safe, comfortable environment to receive specialty medications, including iron infusions, with personalized patient care, education, and counselling.
• A&D Wholesale Wholesale pharmaceutical distribution supplying specialty pharmaceuticals to hospitals, healthcare providers, and pharmacies nationwide.
• NavieGo Programs Patient support programs assisting patients from enrollment and clinical treatments through medication dispensing and adherence, helping ensure patients get maximum benefit from specialty drug therapies. Services contracted by pharmaceutical manufacturers.
• BioScript Logistics Third-party logistics (3PL) service providing a Canadian gateway for global pharma and biotech companies, including specialty medication importation, storage, and distribution.
• AccessLink Access and support service connecting patients to specialty care resources across BioScript's network.
• Iron Infusions Specialized iron infusion treatment service offered at Coverdale Clinics for patients requiring intravenous iron supplementation.

Quantifiable outcome

• Patient satisfaction rate exceeding 90% across 14 pharmacies
• +3 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Nine partnerships are on record, tiered core and minor.

• NeonMind Biosciences Inc.coreStrategic or Co-development Partner · 3 March 2022BioScript Solutions partners with NeonMind BioSciences Inc. to offer novel interventional psychiatry and mental health infusion treatments to underserved Canadians, expanding specialty clinic services into mental health.
• Acorn BiolabsminorStrategic or Co-development Partner · 20 February 2020Acorn Biolabs partners with Coverdale Clinics to offer stem cell and DNA collection appointments, making preservation services more accessible for Canadians.
• Tree CanadaminorStrategic or Co-development PartnerPartnership with Tree Canada supporting reforestation and biodiversity by planting a tree for every new hire, aligning with BioScript's sustainability commitments.
• Canadian Centre for Diversity and Inclusion (CCDI)coreStrategic or Co-development PartnerProud partner of CCDI, dedicated to building a collaborative and inclusive work environment with Diversity, Inclusion, Belonging & Equity Committee actively shaping company culture.
• MS Society of CanadacoreStrategic or Co-development PartnerProud contributors to MS Society of Canada's Acts of Greatness Campaign, helping bring new research breakthroughs and better support for people affected by MS. National sponsors of MS Walk.
• Crohn's and Colitis CanadacoreStrategic or Co-development PartnerNational sponsor of Crohn's and Colitis Canada's Gutsy Walk, supporting patient-focused fundraising for inflammatory bowel disease research and support.
• Indigenous Pharmacy Professionals of CanadaminorStrategic or Co-development PartnerProud sponsor of the Indigenous Pharmacy Scholarship, founded by Indigenous Pharmacy Professionals of Canada and Canadian Pharmacists Association in 2023, supporting future indigenous pharmacy professionals.
• Science Based Targets initiative (SBTi)coreOthersBioScript's science-based greenhouse gas reduction targets officially validated by SBTi in 2025, confirming goals align with 1.5°C global climate pathway.
• CDP (Carbon Disclosure Project)minorOthersAnnual disclosure to CDP ensuring transparency and accountability in tracking environmental progress.

Scale indicators7 records

Recent moves9 records

Expansion highlights6 records

Direct peers

• Innomar Strategies: Canada's leading specialty pharmacy and patient support provider, owned by Cencora (formerly AmerisourceBergen). Directly comparable to BioScript across specialty pharmacy, PSPs, and biologic distribution in Canada.
• McKesson Canada: Wholesale pharmaceutical distributor and specialty pharma services provider in Canada, including pharmacy distribution and 3PL. Comparable to BioScript's A&D Wholesale and BioScript Logistics arms.
• Bayshore HealthCare: Canadian home and community health services provider with specialty pharmacy, infusion, and patient support services. Closely comparable to BioScript's clinic and home-care specialty offerings.
• Kohl & Frisch: Canadian pharmaceutical wholesaler and distribution company. Comparable to BioScript's A&D Wholesale business in distributing drugs to pharmacies and hospitals nationwide.

Broad incumbents

• Shoppers Drug Mart Specialty Health Network: Canada's largest retail pharmacy chain with an embedded specialty pharmacy offering. Overlaps with BioScript Pharmacy on dispensing and chronic-disease specialty care.
• Cencora (formerly AmerisourceBergen): Global pharmaceutical distribution and specialty services giant, parent of Innomar Strategies in Canada. Competes with BioScript Logistics/A&D Wholesale on biologic distribution and with Innomar on Canadian specialty pharmacy.

Regional players

• Option Care Health: Largest US independent provider of home and alternate-site infusion services, currently expanding via the BioScrip merger. Compares to Coverdale Clinics' infusion/injection model, though US-focused.
• Pharmasave: Canadian independent pharmacy network with growing specialty pharmacy and clinical services footprint. Comparable to BioScript Pharmacy at the specialty-dispensing and patient-care level.

Emerging players

• Lovell Drugs / Guardian and I.D.A. Pharmacy: Canadian retail pharmacy networks increasingly focused on specialty services. Partial overlap with BioScript Pharmacy on dispensing and clinical services in select provinces.
• Wellbeings Pain Management and Specialty Clinics: Canadian specialty infusion and chronic pain clinic operator with smaller scale. Comparable to Coverdale Clinics' infusion service model, though geographically narrower.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/BioScriptSolutions
• LinkedInlinkedin.com/company/bioscriptsolutions

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Subsidiaries6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BioScript Solutions